U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
109261109261Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)CompletedNo Results AvailableGraft Versus Host DiseaseDrug: Rituximab|Drug: Ciclosporine|Drug: Corticosteroidshttps://ClinicalTrials.gov/show/NCT01135641
109262109262Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic EncephalopathyCompletedNo Results AvailableHepatic Cirrhosis|Minimal Hepatic EncephalopathyOther: Auxiliary Treatment|Dietary Supplement: Hyperproteic and fiber-rich diet|Drug: Nitazoxanidehttps://ClinicalTrials.gov/show/NCT01135628
109263109263Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)CompletedNo Results AvailableWe Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.Drug: Sevelamer|Drug: calcium acetatehttps://ClinicalTrials.gov/show/NCT01135615
109264109264Topiramate for Hospitalized Patients With Alcoholism: a 12-week StudyRecruitingNo Results AvailableAlcohol DependenceDrug: Topiramatehttps://ClinicalTrials.gov/show/NCT01135602
109265109265Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell TransplantationRecruitingNo Results AvailableNeutropenia|Hematopoietic Stem Cell Transplantation|Invasive Fungal DiseaseDrug: Micafunginhttps://ClinicalTrials.gov/show/NCT01135589
109266109266Iron Fortified Beverages and Application in Women Predisposed to AnemiaCompletedNo Results AvailableIron-deficiency AnemiaDietary Supplement: non-fortified fruit juices consumed as part of the usual diet|Dietary Supplement: Iron fortified fruit juicehttps://ClinicalTrials.gov/show/NCT01135576
109267109267Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System TumorsCompletedNo Results AvailableSolid Tumors|Central Nervous System TumorsDrug: Vinblastine and Sirolimushttps://ClinicalTrials.gov/show/NCT01135563
109268109268Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal RadiationActive, not recruitingNo Results AvailableVomiting|HeadacheDrug: High dose dexamethasone|Drug: Low dose dexamethasonehttps://ClinicalTrials.gov/show/NCT01135550
109269109269Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell TransplantsCompletedNo Results AvailableMalignancy|Metabolic Disease|Genetic DisorderBiological: Thymoglobulin (rATG)https://ClinicalTrials.gov/show/NCT01135537
109270109270Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension PhaseTerminatedHas ResultsOsteoarthritisDrug: Buprenorphine transdermal patch|Drug: Buprenorphine transdermal patch|Drug: Buprenorphine transdermal patchhttps://ClinicalTrials.gov/show/NCT01135524
109271109271A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye DiseaseCompletedHas ResultsDry Eye SyndromesDrug: CP-690,550 Eye drops|Drug: CP-690,550 Eye drops|Drug: CP-690,550 Eye drops|Drug: CP-690,550 Eye drops-vehicle|Drug: Sodium Hyaluronatehttps://ClinicalTrials.gov/show/NCT01135511
109272109272A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.CompletedHas ResultsColorectal CancerDrug: bevacizumab [Avastin]|Drug: eloxatin|Drug: capecitabine [Xeloda]|Drug: erlotinib [Tarceva]https://ClinicalTrials.gov/show/NCT01135498
109273109273Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart SyndromeActive, not recruitingNo Results AvailableCongenital Heart Diseasehttps://ClinicalTrials.gov/show/NCT01135485
109274109274Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Esomeprazole Magnesiumhttps://ClinicalTrials.gov/show/NCT01135472
109275109275A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus ErythematosusCompletedNo Results AvailableSystemic Lupus ErythematosusDrug: CEP-33457|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01135459
109276109276Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy SubjectsCompletedNo Results AvailableType 2 DiabetesDrug: dapagliflozin|Drug: dapagliflozin|Drug: dapagliflozin|Drug: dapagliflozin|Drug: dapagliflozin|Drug: dapagliflozinhttps://ClinicalTrials.gov/show/NCT01135446
109277109277A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: ASP1941|Drug: Placebo|Drug: metforminhttps://ClinicalTrials.gov/show/NCT01135433
109278109278Dual Diagnosis Inpatients: Telephone Monitoring RCT to Improve OutcomesActive, not recruitingNo Results AvailableDiagnosis, Dual (Psychiatry)Behavioral: Telephone Monitoring (TM) with Motivational Interviewing|Other: Usual carehttps://ClinicalTrials.gov/show/NCT01135420
109279109279Visual Selective Attention in Parkinson's DiseaseCompletedNo Results AvailableVisual Attention in Parkinson's DiseaseOther: Recording during computerized tests|Other: Recording during computerized tests|Other: Recording during computerized testshttps://ClinicalTrials.gov/show/NCT01135407
109280109280Pharmacogenomics of ThiazolidinedionesEnrolling by invitationNo Results AvailableType 2 DiabetesDrug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT01135394
109281109281IVR-Enhanced Care Transition Support for Complex PatientsCompletedHas ResultsCongestive Heart Failure|Chronic Obstructive Pulmonary DiseaseBehavioral: IVR-Enhanced Carehttps://ClinicalTrials.gov/show/NCT01135381
109282109282Safety and Efficacy of Lansoprazole in Patients With Reflux DiseaseCompletedHas ResultsGastroesophageal RefluxDrug: Lansoprazolehttps://ClinicalTrials.gov/show/NCT01135368
109283109283Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant RecipientsRecruitingNo Results AvailableStem Cell Transplantation|Blood and Marrow Transplant (BMT)https://ClinicalTrials.gov/show/NCT01135355
109284109284Adding Sleep Intervention to Traditional Diet and Exercise Approach to Weight LossCompletedNo Results AvailableSleep Initiation and Maintenance Disorders|ObesityBehavioral: Weight Loss Regimen and Sleep Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT01135342
109285109285Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic CancersTerminatedNo Results AvailableLymphoma|Leukemia|Myelodysplastic SyndromeDrug: Fludarabine, Busulfan, Cyclophosphamide, Tacrolimus,https://ClinicalTrials.gov/show/NCT01135329
109286109286Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MRCompletedNo Results AvailableNephrogenic Systemic FibrosisDrug: Ablavarhttps://ClinicalTrials.gov/show/NCT01135316
109287109287Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea SyndromeCompletedNo Results AvailableSleep Apnea SyndromesDevice: VistaO2 devicehttps://ClinicalTrials.gov/show/NCT01135303
109288109288Post Treatment Care After Chemical Peel or Laser ResurfacingWithdrawnNo Results AvailableChemical PeelDrug: Aquaphor|Drug: HP828-101https://ClinicalTrials.gov/show/NCT01135290
109289109289Immune Suppression and Ventilator Associated PneumoniasEnrolling by invitationNo Results AvailableSepsishttps://ClinicalTrials.gov/show/NCT01135277
109290109290Cognitive-Motivational Behavior Therapy for Pathological GamblersRecruitingNo Results AvailablePathological GamblingBehavioral: CBT|Behavioral: CMBThttps://ClinicalTrials.gov/show/NCT01135264

* Görseller ve İçerik tekif hakkına sahip olabilir